Correlation between Alkaline Phosphatase and Neonatal Jaundice

Area of Science:

• Neonatology
• Biochemistry
• Pediatrics

Background:

• Neonatal hyperbilirubinemia is a common disorder with potential neurological risks.
• Pathological jaundice requires careful monitoring and understanding of contributing factors.
• Alkaline phosphatase (ALP) is an enzyme whose role in neonatal jaundice is under investigation.

Purpose of the Study:

• To evaluate the correlation between alkaline phosphatase (ALP) levels and pathological jaundice in term neonates.
• To compare ALP levels in neonates with and without pathological jaundice.
• To explore relationships between ALP, serum total bilirubin, and clinical factors.

Main Methods:

• A case-control study involving 153 term neonates with pathological jaundice and 153 controls.
• Biochemical tests were used to measure serum total bilirubin and alkaline phosphatase (ALP) levels.
• Clinical data, including jaundice severity, hospitalization duration, and delivery type, were recorded.

Main Results:

• Mean ALP levels were significantly higher in the pathological jaundice group (411.3 U/L) compared to the control group (338 U/L).
• No significant correlation was found between ALP levels and serum total bilirubin in neonates with pathological jaundice.
• ALP levels showed a significant relationship with the type of delivery but not with gender or hospitalization duration.

Conclusions:

• The study indicates no direct correlation between alkaline phosphatase levels and pathological jaundice in neonates.
• Elevated ALP levels in jaundiced neonates warrant further investigation.
• Additional studies are recommended to validate these findings and clarify the role of ALP in neonatal hyperbilirubinemia.